Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals

Ruchika Sharma23 Dec 2022 3:31 PM IST

iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.

SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal Vaccine

COVID vaccine: SII seeks DCGI nod for market authorisation of Covovax as booster dose

Ruchika Sharma23 Dec 2022 2:30 PM IST

New Delhi: The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its COVID-19 vaccine Covovax as a...

Dr Mansukh Mandaviya inaugurates new building of CDSCO Bhawan, South Zone in Chennai

Ruchika Sharma23 Dec 2022 1:30 PM IST

New Delhi: Union Minister of Health & Family Welfare Dr. Mansukh Mandaviya has virtually inaugurated the new building of CDSCO Bhawan, South...

Lupin arm recalls high BP drug Quinapril in US over presence of nitrosamine impurity

Ruchika Sharma23 Dec 2022 12:30 PM IST

The company advised patients taking the Quinapril tablets "to continue taking their medication and contact their pharmacist, physician, or medical...

Glenmark Pharma unveils triple FDC Zita-PioMet for Type 2 diabetes in India

Ruchika Sharma23 Dec 2022 11:15 AM IST

This offers patients with Type 2 diabetes the convenience of once-daily dosing to improve their glycemic control and achieve the targeted HbA1c within...

Zydus Lifesciences subsidiary bags USFDA nod to market pulmonary arterial hypertension drug Selexipag

Ruchika Sharma22 Dec 2022 4:35 PM IST

The drug will be manufactured in the group’s formulation manufacturing facility at Ahmedabad SEZ, India.

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Biocon Biologics recognized as Company with Great Managers at Great Manager Awards 2022

Ruchika Sharma22 Dec 2022 3:45 PM IST

The Great Manager Awards Program, an initiative by global human resource management consulting firm People Business, identifies, recognizes, and...

Alembic Pharma gets four USFDA observations for Panelav facility

Alembic Pharma gets PAS approval from USFDA for Pregabalin Capsules

Ruchika Sharma22 Dec 2022 3:32 PM IST

Pregabalin Capsules are indicated for neuropathic pain, postherpetic neuralgia, and other indications.

Merck secures USFDA priority review for PADCEV with KEYTRUDA for treatment of Urothelial Cancer

Ruchika Sharma22 Dec 2022 3:21 PM IST

PADCEV (enfortumab vedotin-ejfv) is a first-in-class antibody-drug conjugate (ADC) that is directed against Nectin-4, a protein located on the surface...

Shilpa Medicare unveils Capecitabine 1000 MG dispersible tablet for breast cancer

Ruchika Sharma22 Dec 2022 2:00 PM IST

With the introduction of Shilpa's new brand, "Capebel", patients will be required to just drop the tablets in 100 mL water and allow the tablets to...

Boehringer Ingelheim appoints Shashank Deshpande, Paola Casarosa to Board of Managing Directors

Ruchika Sharma22 Dec 2022 12:45 PM IST

The appointment to the Board of Managing Directors will be effective July 1, 2023 for Paola Casarosa and September 1, 2023 for Shashank Deshpande.

Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Roche Actemra gets USFDA okay to treat COVID in hospitalised adults

Ruchika Sharma22 Dec 2022 11:15 AM IST

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizumab) intravenous (IV) for the treatment of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok